Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Absci CorpABSI · Entity 4685 | Chief Technology Officer | February 21, 2022 | February 23, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Absci Corp
Report date February 21, 2022 · Filed February 23, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.27 · Expires 2032-02-20 | Direct | 215,000 |
Reported balance
After 2022-02-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-02-21 · Grant · Acquired 215,000 · Balance 215,000 F1: 25% of the shares subject to this option vest and become exercisable on February 18, 2023, and thereafter, the remaining shares subject to this option vest and become exercisable in 36 approximately equal monthly installments until February 18, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of the shares subject to this option vest and become exercisable on February 18, 2023, and thereafter, the remaining shares subject to this option vest and become exercisable in 36 approximately equal monthly installments until February 18, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2022 Filed Feb 23, 2022 21:39 UTC | Absci Corp ABSI · Entity 4685 | GrantStock Option (right to buy) · Derivative | 215,000 | $0.00 Strike: $8.27 | $0.00 |
DisclosureSEC source: 0001628280-22-003609 · wf-form4_164567036457365.xml · derivative · entry 1 Weinstock Matthew · CIK 0001872373 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,000 Underlying: Common Stock · 215,000 shares Expires 2032-02-20 F1 · derivative.exercise_date: 25% of the shares subject to this option vest and become exercisable on February 18, 2023, and thereafter, the remaining shares subject to this option vest and become exercisable in 36 approximately equal monthly installments until February 18, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.